FrancophonIA/ELRC3.0 huggingface dataset:
English: Aerius 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 90 or 100 tablets.
Maltese: Aerius pilloli ta' 5 mg miksija b'rita huma ppakkjati f'folji f'pakketti ta' 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50, 90 jew 100 pillola.
English: In clinical studies in adults, side effects were about the same as with a dummy tablet.
Maltese: Fi studji kliniċi fl-adulti, l-effetti sekondarji kienu rrappurtati kważi daqs kemm ikun hemm b'pillola finta.
English: The safety of desloratadine in children 2- to 11-years of age who are poor metabolisers is the same as in children who are normal metabolisers.
Maltese: Is-sigurtà ta' desloratadine fi tfal ta' etajiet bejn sentejn u 11-il sena li huma metabolizzaturi dgħajfin hija l-istess bħal dik fi tfal li huma metabolizzaturi normali.
English: In an additional study, no adverse events were seen in subjects between 6 and 11 years of age following a single 2.5 mg dose of desloratadine oral solution.
Maltese: Fi studju ieħor, ma ġewx osservati każi avversi f'individwi ta' etajiet bejn 6 u 11-il sena wara doża waħda ta' 2.5 mg ta' soluzzjoni orali ta' desloratadine.
English: The most frequent of adverse events reported in excess of placebo were fatigue (1.2 %), dry mouth (0.8 %) and headache (0.6 %).
Maltese: L-aktar reazzjonijiet avversi frekwenti li kienurrappurtati aktar minn dak tal-plaċebo kienu għeja (1.2%), ħalq xott (0.8%), u uġigħ ta' ras (0.6%).
English: An improvement in pruritus of more than 50 % was observed in 55 % of patients treated with desloratadine compared with 19 % of patients treated with placebo.
Maltese: Titjib fil-ħakk ta' aktar minn 50% deher f'55% talpazjenti kkurati b'desloratadine imqabbel ma' 19% tal-pazjenti kkurati bi plaċebo.
English: Very rare: the following may affect up to 1 in 10,000 people
Maltese: Rari ħafna: dawn li ġejjin jistgħu jaffettwaw sa persuna 1 minn kull 10,000
English: ● pounding or irregular heartbeat
Maltese: ● imġiba mhux normali
English: Based on a multiple dose clinical trial, in which up to 45 mg of desloratadine was administered (nine times the clinical dose), no clinically relevant effects were observed.
Maltese: Abbażi ta' prova klinika b'ħafna dożi, li fiha ngħataw sa 45 mg ta' desloratadine (disa' darbiet id-doża klinika), ma ġew osservati l-ebda effetti kliniċi rilevanti.
English: There is no evidence of clinically relevant active substance accumulation following once daily adult and adolescent dosing of desloratadine (5 mg to 20 mg) for 14 days.
Maltese: M'hemmx evidenza ta' akkumulazzjoni rilevanti b'mod kliniku tal-mediċina wara li jingħata dożaġġ ta' desloratadine darba kuljum (5 mg sa 20 mg) lill-adolexxenti u lill-adulti għal 14-il ġurnata.
English: When given at the recommended doses, the plasma concentrations of desloratadine (see section 5.2) were comparable in the paediatric and adult populations.
Maltese: Meta ngħata bid-dożi rakkomandati, il-konċentrazzjonijiet ta' desloratadine fil-plażma (ara sezzjoni 5.2) kienu komparabbli fil-popolazzjonijiet pedjatriċi ma' dawk adulti.
English: Maximum desloratadine concentration was about 3-fold higher at approximately 7 hours with a terminal phase half-life of approximately 89 hours.
Maltese: Il-konċentrazzjoni massima ta' desloratadine kienet daqs 3 darbiet ogħla wara madwar 7 sigħat, bil-fażi terminali tal-half life ta' madwar 89 siegħa.
English: Aerius oral solution is available in bottles of 30, 50, 60, 100, 120, 150, 225 and 300 ml, with a childproof cap. For all packages except the 150 ml bottle, a measuring spoon is provided, marked for doses of 2.5 ml and 5 ml.
Maltese: Aerius soluzzjoni orali , jiġi fi fliexken ta' daqsijiet ta' 30, 50, 60, 100, 120, 150, 225 u 300 ml magħluqin b'għatu tal-plastik mhux faċli biex jiftħuh it-tfal.
English: Jaundice
Maltese: Sentejn
English: Packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 orodispersible tablets.
Maltese: Pakketti ta' 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 u 100 pillola li jinħallu fil-ħalq.
English: Aerius is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Maltese: Aerius huwa indikat fl-adulti, fl-adolexxenti minn 12-il sena 'l fuq u tfal ta' bejn 6 u 11-il sena biex jittaffew is-sintomi assoċjati ma': - rinite allerġika (ara sezzjoni 5.1) - urtikarja (ara sezzjoni 5.1)
English: Aerius is an antiallergy medicine that does not make you drowsy.
Maltese: Aerius hija mediċina kontra l-allerġiji li ma traqqdekx.
English: As a precautionary measure, it is preferable to avoid the use of Aerius during pregnancy.
Maltese: Bћala prekawzjoni hu preferribli li ma jintużax Aerius waqt it-tqala.
English: Aerius oral solution is an antiallergy medicine that does not make you drowsy.
Maltese: Aerius soluzzjoni orali hija mediċina kontra l-allerġiji li ma traqqdekx.
English: Desloratadine plasma concentrations can be detected within 30 minutes of administration.
Maltese: Il-konċentrazzjonijiet ta' desloratadine fil-plażma jkunu jistgħu jitkejlu fi żmien 30 minuta minn meta jingħata.
English: Aerius effectively controlled symptoms for 24 hours.
Maltese: Aerius ikkontrollaw is-sintomi b'mod effettiv għal 24 siegħa.
English: The degree of accumulation of desloratadine was consistent with its half-life (approximately 27 hours) and a once daily dosing frequency.
Maltese: Il-grad ta' akkumulazzjoni ta' desloratadine kien jaqbel mal-half-life tiegħu (madwar 27 siegħa) u l-frekwenza ta' dożaġġ ta' darba kuljum.
English: How to store Aerius
Maltese: X'inhu Aerius
English: ● stomach ache
Maltese: ● ħalq xott
English: In a clinical pharmacology trial, in which desloratadine was administered at a dose of 45 mg daily (nine times the clinical dose) for ten days, no prolongation of QTc interval was seen.
Maltese: Fi prova klinika farmakoloġika, li fiha ngħata desloratadine b'doża ta' 45 mg kuljum (disa' darbiet id-doża klinika) għal għaxart ijiem, ma ġiet osservata l-ebda żieda fit-tul tal-intervall tal-QTc.
English: EU/1/00/160/037 5 orodispersible tablets EU/1/00/160/038 6 orodispersible tablets EU/1/00/160/039 10 orodispersible tablets EU/1/00/160/040 12 orodispersible tablets EU/1/00/160/041 15 orodispersible tablets EU/1/00/160/042 18 orodispersible tablets EU/1/00/160/043 20 orodispersible tablets EU/1/00/160/044 30 orodispersible tablets EU/1/00/160/045 50 orodispersible tablets EU/1/00/160/046 60 orodispersible tablets EU/1/00/160/047 90 orodispersible tablets EU/1/00/160/048 100 orodispersible tablets
Maltese: EU/1/00/160/037 5 pilloli li jinħallu fil-ħalq EU/1/00/160/038 6 pilloli li jinħallu fil-ħalq EU/1/00/160/039 10 pilloli li jinħallu fil-ħalq EU/1/00/160/040 12-il pillola li jinħallu fil-ħalq EU/1/00/160/041 15-il pillola li jinħallu fil-ħalq EU/1/00/160/042 18-il pillola li jinħallu fil-ħalq EU/1/00/160/043 20 pillola li jinħallu fil-ħalq EU/1/00/160/044 30 pillola li jinħallu fil-ħalq EU/1/00/160/045 50 pillola li jinħallu fil-ħalq EU/1/00/160/046 60 pillola li jinħallu fil-ħalq EU/1/00/160/047 90 pillola li jinħallu fil-ħalq EU/1/00/160/048 100 pillola li jinħallu fil-ħalq
English: No special requirements.
Maltese: ilma purifikat
English: The lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.
Maltese: In-nuqqas ta' potenzjal li jikkawża l-kanċer intwera bi studji li saru b'desloratadine u loratadine.
English: In a pharmacokinetic trial in which patient demographics were comparable to those of the general seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration of desloratadine.
Maltese: Fi prova farmakokinetika fejn il-karatteristiċi demografiċi tal-pazjenti kienu jaqblu ma' dawk talpopolazzjoni ġenerali b'rinite allerġika tal-istaġun, 4% tal-individwi kisbu konċentrazzjoni ogħla ta' desloratadine.
English: Aerius 2.5 mg tablets has not been evaluated in paediatric patients however in conjunction with the dose finding studies in paediatrics, the pharmacokinetics data for Aerius orodispersible tablets supports the use of the 2.5 mg dose in paediatric patients 6 to 11 years of age.
Maltese: Il-pilloli Aerius 2.5 mg ma ġewx evalwati f'pazjenti pedjatriċi, madankollu b'relazzjoni mal-istudji dwar is-sejbiet tad-doża fit-tfal, id-dejta farmakokinetika għall-pilloli li jinħallu fil-ħalq Aerius tiffavorixxi l-użu tad-doża ta' 2.5 mg f'pazjenti pedjatriċi bejn 6 u 11-il sena.
English: Aerius orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet.
Maltese: Aerius pillola li tinħall fil-ħalq hi ppakkjata f'folji b'doża waħda f'pakketti ta' 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 u 100 doża ta' pilloli li jinħallu fil-ħalq.
English: No clinically relevant changes in desloratadine plasma concentrations were observed in multiple-dose ketoconazole and erythromycin interaction trials.
Maltese: Ma ġie osservat l-ebda tibdil kliniku rilevanti tal-konċentrazzjonijiet ta' desloratadine fil-plażma fi provi ta' interazzjoni b'ħafna dożi ta' ketoconazole u erythromycin.
English: At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Aerius were reported in 3 % of patients in excess of those treated with placebo.
Maltese: Fid-doża rakkomandata, fi provi kliniċi li saru f'adulti u adolexxenti f'medda ta' indikazzjonijiet fosthom rinite allerġika u urtikarja idjopatika kronika, l-effetti mhux mixtieqa ta' Aerius kienu rrappurtati fi 3% tal-pazjenti aktar minn dawk ikkurati bi plaċebo.
English: ● slow heartbeat
Maltese: ● infjammazjoni tal-fwied
English: How to take Aerius oral solution
Maltese: X'fih Aerius soluzzjoni orali
English: Aerius tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials.
Maltese: Il-pilloli Aerius mogħtija bħala doża waħda kuljum ta' 7.5 mg lill-adulti u adolexxenti ma affettwawx il-prestazzjonijiet psikomotorei fi provi kliniċi.
English: Aerius relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older.
Maltese: Aerius itaffi s-sintomi assoċjati ma' rinite allerġika (infjammazzjoni tal-passaġġi fl-imnieħer ikkawżata minn allerġija, pereżempju hay fever jew allerġija għad-dust mites) fl-adulti u fl-adolexxenti minn 12-il sena 'l fuq.
English: Aerius is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1)
Maltese: Aerius huwa indikat fl-adulti u fl-adolexxenti minn 12-il sena 'l fuq biex jittaffew is-sintomi assoċjati ma': - rinite allerġika (ara sezzjoni 5.1) - urtikarja (ara sezzjoni 5.1)
English: EU/1/00/160/049 5 orodispersible tablets EU/1/00/160/050 6 orodispersible tablets EU/1/00/160/051 10 orodispersible tablets EU/1/00/160/052 12 orodispersible tablets EU/1/00/160/053 15 orodispersible tablets EU/1/00/160/054 18 orodispersible tablets EU/1/00/160/055 20 orodispersible tablets EU/1/00/160/056 30 orodispersible tablets EU/1/00/160/057 50 orodispersible tablets EU/1/00/160/058 60 orodispersible tablets EU/1/00/160/059 90 orodispersible tablets EU/1/00/160/060 100 orodispersible tablets
Maltese: EU/1/00/160/049 5 pilloli li jinħallu fil-ħalq EU/1/00/160/050 6 pilloli li jinħallu fil-ħalq EU/1/00/160/051 10 pilloli li jinħallu fil-ħalq EU/1/00/160/052 12-il pillola li jinħallu fil-ħalq EU/1/00/160/053 15-il pillola li jinħallu fil-ħalq EU/1/00/160/054 18-il pillola li jinħallu fil-ħalq EU/1/00/160/055 20 pillola li jinħallu fil-ħalq EU/1/00/160/056 30 pillola li jinħallu fil-ħalq EU/1/00/160/057 50 pillola li jinħallu fil-ħalq EU/1/00/160/058 60 pillola li jinħallu fil-ħalq EU/1/00/160/059 90 pillola li jinħallu fil-ħalq EU/1/00/160/060 100 pillola li jinħallu fil-ħalq
English: In clinical trials, desloratadine in the syrup formulation was administered to a paediatric population.
Maltese: Kura tas-sintomi u ta' appoġġ hija rakkomandata.
English: Aerius orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding.
Maltese: Aerius pillola li tinħall fil-ħalq hija mediċina kontra l-allerġiji li ma traqqdekx.
English: Desloratadine is not eliminated by haemodialysis; it is not known if it is eliminated by peritoneal dialysis.
Maltese: Desloratadine ma jiġix eliminat bl-emodijalisi; mhux magħruf jekk jiġix eliminat b'dijalisi tal peritonew.
English: Not known: frequency cannot be estimated from the available data ● unusual weakness
Maltese: Mhux magħruf: ma tistax tittieħed stima tal-frekwenza mid-dejta disponibbli ● dgħufija mhux tas-soltu
English: ● liver inflammation ● abnormal liver function tests body movement
Maltese: ● testijiet tal-funzjoni tal-fwied mhux normali
English: Aerius tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials.
Maltese: Il-pilloli Aerius mogħtija bħala doża waħda kuljum ta' 7.5 mg ma affettwawx il-prestazzjonijiet psikomotorei fi provi kliniċi.
English: EU/1/00/160/001-013 EU/1/00/160/036
Maltese: EU/1/00/160/001 Pillola 1
English: Each tablet contains 5 mg desloratadine.
Maltese: Kull pillola fiha 5 mg desloratadine.
English: Tachycardia, palpitations QT prolongation
Maltese: Titwil tal-intervall QT
English: ● hallucinations
Maltese: ● aċċessjonijiet
English: Adverse reactions seen with Aerius
Maltese: Reazzjonijiet avversi li dehru b'Aerius
English: Desloratadine has demonstrated antiallergic properties from in vitro studies.
Maltese: u testijiet xierqa tal-laboratorju u tal-ġilda.
English: ● rash
Maltese: OĦRAJN
English: Since histamine release is a causal factor in all urticarial diseases, desloratadine is expected to be effective in providing symptomatic relief for other urticarial conditions, in addition to chronic idiopathic urticaria, as advised in clinical guidelines.
Maltese: Fi provi kliniċi ta' medda ta' indikazzjonijiet fosthom rinite allerġika u urtikarja idjopatika kronika,
English: During the marketing of Aerius, the following side effects were reported as:
Maltese: Matul it-tqegħid fis-suq ta' Aerius, l-effetti sekondarji li ġejjin ġew irrappurtati bħala:
English: Aerius 5 mg film-coated tablets desloratadine
Maltese: Aerius 5 mg pillola li tinħall fil-ħalq desloratadine
English: Oral use Read the package leaflet before use.
Maltese: Jista' jkun li mhux il pakketti tad-daqsijiet kollha jkunu fis-suq.
English: These include inhibiting the release of proinflammatory cytokines such as IL-4, IL-6, IL-8, and IL-13 from human mast cells/basophils, as well as inhibition of the expression of the adhesion molecule P-selectin on endothelial cells.
Maltese: Dawn kienu jinkludu l-inibizzjoni tal-ħelsien ta' ċitokini li jgħinu l-infjammazzjoni bħal IL-4, IL-6, IL-8 u IL-13 miċ-ċelluli mast/bażofili tal-bniedem, kif ukoll inibizzjoni fl-espressjoni tal-molekula ta' adeżjoni P-selectin fuq iċ-ċelluli endoteljali.
English: This product contains 2.9 mg of phenylalanine per 5 mg dose of Aerius orodispersible tablet.
Maltese: Dan il-prodott fih 2.9 mg ta' phenylalanine għal kull doża ta' 5 mg ta' pillola li tinħall fil-ħalq Aerius.
English: In the single-dose study, the exposure to desloratadine was approximately 2 and 2.5-fold greater in subjects with mild to moderate and severe CRI, respectively, than in healthy subjects.
Maltese: Fl-istudju b'doża waħda, l-esponiment għal desloratadine kien madwar 2 u 2.5 drabi aktar f'individwi b'CRI minn ħafifa sa moderata u severa, rispettivament, milli f'individwi f'saħħithom.
English: In single-dose crossover studies of Aerius 5 mg orodispersible tablets with Aerius 5 mg conventional tablets, the formulations were bioequivalent.
Maltese: bid-doża rakkomandata ta' 5 mg kuljum, l-effetti mhux mixtieqa bil-pilloli Aerius kienu rrappurtati fi 3% tal-pazjenti aktar minn dawk ikkurati bi plaċebo.
English: Do not take Aerius oral solution - if you are allergic to desloratadine, or to any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Maltese: Tiħux Aerius soluzzjoni orali - jekk inti allerġiku għal desloratadine jew għal xi sustanza oħra ta' din il-mediċina (imniżżla fis sezzjoni 6) jew għal loratadine.
English: Fatigue Fever
Maltese: Żieda fil-piż
English: In adult and adolescent patients with allergic rhinitis, Aerius tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate.
Maltese: F'pazjenti adulti u adolexxenti b'rinite allerġika, il-pilloli Aerius kienu effettivi biex iserrħu sintomi bħal għatis, tnixxija mill-imnieħer u ħakk, kif ukoll ħakk, dmugħ u ħmura fl-għajnejn, u ħakk fis-saqaf tal-ħalq.
English: In addition to the established classifications of seasonal and perennial, allergic rhinitis can alternatively be classified as intermittent allergic rhinitis and persistent allergic rhinitis according to the duration of symptoms.
Maltese: Minbarra l-klassifikazzjonijiet stabbiliti tal-istaġun u perenni, rinite allerġika tista' minflok tkun ikklassifikata bħala rinite allerġika intermittenti u rinite allerġika persistenti skont kemm idumu ssintomi.
English: Use caution when taking Aerius with alcohol.
Maltese: Oqgħod attent meta tieħu Aerius mal-alkoħol.
English: In a multiple-dose clinical trial, in which up to 20 mg of desloratadine was administered daily for 14 days, no statistically or clinically relevant cardiovascular effect was observed.
Maltese: Fi prova klinika b'ħafna dożi, li fiha sa 20 mg ta' desloratadine ngħataw kuljum għal 14-il ġurnata, ma ġie osservat l-ebda effett kardjovaskulari klinikament jew statistikament rilevanti.
English: Phenylalanine may be harmful for people with phenylketonuria.
Maltese: Phenylalanine jista' jagħmel il-ħsara f'pazjenti li jbatu minn fenilketonurija.
English: Non-clinical studies conducted with desloratadine and loratadine demonstrated that there are no qualitative or quantitative differences in the toxicity profile of desloratadine and loratadine at comparable levels of exposure to desloratadine.
Maltese: Studji li mhumiex kliniċi li saru b'desloratadine u loratadine urew li m'hemmx differenzi mill-lat kwalitattiv jew kwantitattiv fil-profil ta' tossiċità ta' desloratadine u loratadine f'livelli komparabbli ta'esponiment għal desloratadine.
English: Aspartame is a source of phenylalanine, which may be harmful for people with phenylketonuria.
Maltese: Aspartame huwa sors ta' phenylalanine, li jista' jkun ta' ħsara għal nies li jbatu b'fenilketonurija.
English: Aerius orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 6 years of age and older.
Maltese: Aerius pillola li tinħall fil-ħalq itaffi s-sintomi assoċjati ma' rinite allerġika (infjammazzjoni talpassaġġi fl-imnieħer ikkawżata minn allerġija, pereżempju hay fever jew allerġija għad-dust mites) fladulti, fl-adolexxenti u fit-tfal minn 6 snin 'il fuq.
English: Adults and adolescents (12 years of age and over) The recommended dose of Aerius is 10 ml (5 mg) oral solution once a day.
Maltese: Id-doża rakkomandata ta' Aerius hija ta' 10 ml (5 mg) ta' soluzzjoni orali darba kuljum.
English: All packages except the 150 ml package are supplied with a measuring spoon marked for doses of 2.5 ml and 5 ml.
Maltese: Għall-pakkett ta' 150 ml, hemm kuċċarina tal-kejl jew siringa biex titkejjel doża mill-ħalq mmarkati għad-dożi tat-2.5 ml u 5 ml.
English: The safety and efficacy of Aerius 0.5 mg/ml oral solution in children below the age of 1 year have not been established.
Maltese: Is-sigurtà u l-effikaċja ta' Aerius 0.5 mg/ml soluzzjoni orali fit-tfal ta' inqas minn sena ma ġewx determinati s'issa.
English: The prevalence of this poor metaboliser phenotype was greater among Black adults than Caucasian adults (18 % vs. 2 %) however the safety profile of these subjects was not different from that of the general population.
Maltese: Il-prevalenza ta' dan il-fenotip ta' metabolizzatur dgħajjef kienet akbar f'adulti Suwed milli f'adulti Kawkasi (18% vs 2%), madankollu fiż-żewġ popolazzjonijiet, il-profil tas-sigurtà ta'
English: BOX OF 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 ORODISPERSIBLE TABLETS
Maltese: TAGĦRIF LI GĦANDU JIDHER FUQ IL-PAKKETT TA' BARRA KAXXA TA' 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90, 100 PILLOLA LI JINĦALLU FIL-ĦALQ
English: The cold form blister film is composed of polyvinyl chloride (PVC) film adhesively laminated to an oriented polyamide (OPA) film, adhesively laminated to aluminum foil, adhesively laminated to polyvinyl chloride (PVC) film.
Maltese: Ir-rita tal-forma kiesħa tal-folja hija magħmula minn rita ta' polyvinyl chloride (PVC) laminata b'kolla ma' rita ta' polyamide orjentat (OPA), laminata b'kolla ma' fojl tal-aluminum, laminata b'kolla ma' rita ta' polyvinyl chloride (PVC).
English: Aerius orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older.
Maltese: Aerius pillola li tinħall fil-ħalq itaffi s-sintomi assoċjati ma' rinite allerġika (infjammazzjoni talpassaġġi fl-imnieħer ikkawżata minn allerġija, pereżempju hay fever jew allerġija għad-dust mites) fladulti u fl-adolexxenti minn 12-il sena 'l fuq.
English: EU/1/16/1141/001 SomaKit TOC 40 micrograms
Maltese: EU/1/16/1141/001 SomaKit TOC
English: Powder for solution for injection: 40 micrograms;
Maltese: 40 mikrogramma;
English: Reaction Buffer: vial (COP)
Maltese: Trab: kunjett (ħġieġ); Baffer ta' Reazzjoni Kunjett (COP)
English: 1 vial + 1 vial
Maltese: Baffer ta' Reazzjoni 1 ml kunjett 1 + kunjett
English: Pack size
Maltese: mikrogram ma
English: Intravenous use Powder: vial (glass);
Maltese: Isem (ivvintat) Qawwa Għamla farmaċewtika
English: ATCvet code: QC09BX90
Maltese: QC09BX90
English: Store below 25 °C.
Maltese: Aħżen f'temperaturi anqas minn 25 °C.
English: Artificial Special Dry Flavour Basic butylated methacrylate copolymer Copovidone
Maltese: Basic butylated methacrylate copolymer Copovidone
English: 26 Rue de la Chapelle F-68330 Huningue
Maltese: Elanco France S.A.S 26 Rue de la Chapelle F-68330 Huningue Franza
English: METHOD AND ROUTE(S) OF ADMINISTRATION Oral use.
Maltese: METODU U MOD(I) TA' AMMINISTRAZZJONI
English: FORTEKOR PLUS is a combination of 2 active substances: pimobendan and benazepril hydrochloride.
Maltese: FORTEKOR PLUS huwa kombinazzjoni ta' 2 sustanzi attivi: pimobendan u benazepril hydrochloride.
English: EU/2/15/185/001 (1 x 30 tablets, 1.25 mg/2.5 mg tablets) EU/2/15/185/002 (1 x 60 tablets, 1.25 mg/2.5 mg tablets) EU/2/15/185/003 (1 x 30 tablets, 5 mg/10 mg tablets) EU/2/15/185/004 (1 x 60 tablets, 5 mg/10 mg tablets)
Maltese: EU/2/15/185/001 (1 x 30 pillola, 1.25 mg/2.5 mg pilloli) EU/2/15/185/002 (1 x 60 pillola, 1.25 mg/2.5 mg pilloli) EU/2/15/185/003 (1 x 30 pillola, 5 mg/10 mg pilloli) EU/2/15/185/004 (1 x 60 pillola, 5 mg/10 mg pilloli)
English: EU/2/15/185/001 (1 x 30 tablets, 1.25 mg/2.5 mg) EU/2/15/185/002 (1 x 60 tablets, 1.25 mg/2.5 mg) EU/2/15/185/003 (1 x 30 tablets, 5 mg/10 mg)
Maltese: EU/2/15/185/001 (1 x 30 pillola, 1.25 mg/2.5 mg) EU/2/15/185/002 (1 x 60 pillola, 1.25 mg/2.5 mg) EU/2/15/185/003 (1 x 30 pillola, 5 mg/10 mg) EU/2/15/185/004 (1 x 60 pillola, 5 mg/10 mg)
English: Benazeprilat is excreted via the biliary (54%) and urinary (46%) routes in dogs.
Maltese: Benazeprilat jitneħħa permezz tar-rotot biljari (54%) u urinarji (46%) fil-klieb.
English: For the full list of excipients, see section 6.1.
Maltese: Għal-lista kompluta ta' eċċipjenti, ara sezzjoni 6.1